TipRanks
Sino Biopharmaceutical Ltd (SBMFF)
OTHER OTC:SBMFF
US Market
SBMFF
Sino Biopharmaceutical
RESEARCH TOOLSreports

Sino Biopharmaceutical (SBMFF) Stock News & Sentiment

44 Followers
Sino Biopharm’s IL-4R Antibody for Atopic Dermatitis Clears Key Regulatory Hurdle in China
Premium
Company Announcements
Sino Biopharm’s IL-4R Antibody for Atopic Dermatitis Clears Key Regulatory Hurdle in China
4d ago
Sino Biopharmaceutical’s HER2-Low Breast Cancer ADC Wins China NDA Acceptance
Premium
Company Announcements
Sino Biopharmaceutical’s HER2-Low Breast Cancer ADC Wins China NDA Acceptance
4d ago
Sino Biopharm Raises CT Tianqing Stake to 65% in RMB4.48 Billion Deal
Premium
Company Announcements
Sino Biopharm Raises CT Tianqing Stake to 65% in RMB4.48 Billion Deal
9d ago
Sino Biopharm Showcases Promising Oral STAT6 Degrader Data at ERS 2026
Premium
Company Announcements
Sino Biopharm Showcases Promising Oral STAT6 Degrader Data at ERS 2026
12d ago
Sino Biopharm’s TQC3721 COPD Inhaler Shows Strong Phase I Data
Premium
Company Announcements
Sino Biopharm’s TQC3721 COPD Inhaler Shows Strong Phase I Data
13d ago
Sino Biopharm Wins FDA Green Light for Novel GPC3-Targeting Cancer ADC Trial
Premium
Company Announcements
Sino Biopharm Wins FDA Green Light for Novel GPC3-Targeting Cancer ADC Trial
16d ago
Sino Biopharm Strikes Exclusive HER2 ADC Deal With Cipla to Boost Emerging-Market Reach
Premium
Company Announcements
Sino Biopharm Strikes Exclusive HER2 ADC Deal With Cipla to Boost Emerging-Market Reach
20d ago
More SBMFF News >

SBMFF News on the Web

Sino Biopharm’s IL-4R Antibody for Atopic Dermatitis Clears Key Regulatory Hurdle in China
TipRanks News
Bullish
Sino Biopharm Raises CT Tianqing Stake to 65% in RMB4.48 Billion Deal
TipRanks News
Bullish
Sino Biopharm’s TQC3721 COPD Inhaler Shows Strong Phase I Data
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Sino Biopharmaceutical (SBMFF) Receives a Buy from Citi
TipRanks News
Bullish
Sino Biopharmaceutical: Strong Profit Beat, Rapid Innovative Franchise Expansion; Buy Rating Reiterated with Unchanged $7.8 Price Target
TipRanks News
Bullish
Sino Biopharmaceutical (SBMFF) Receives a Buy from UBS
TipRanks News
Bullish
Sino Biopharmaceutical Forms Indonesia Joint Venture With Tempo Scan
TipRanks News
Bullish

News Score - Last 7 Days

Positive
SBMFF
Sector Average
Media Buzz
This Week2 articles
Weekly Average4.5 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SBMFF’s Media Buzz Sentiment?
2 articles about SBMFF were published this week. In an average week, 4.5 articles are published.
    What is SBMFF’s weekly average amount of articles?
    In an average week, 4.5 articles about SBMFF are published.
      What is SBMFF’s News Sentiment?
      100% of articles about SBMFF were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        CRLCharles River Labs
        DFTXDefinium Therapeutics
        AMRXAmneal Pharmaceuticals
        SMMTSummit Therapeutics
        ABEOAbeona Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week